199 related articles for article (PubMed ID: 12520163)
1. Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
Itabe H
Biol Pharm Bull; 2003 Jan; 26(1):1-9. PubMed ID: 12520163
[TBL] [Abstract][Full Text] [Related]
2. [Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody].
Itabe H
Yakugaku Zasshi; 2002 Oct; 122(10):745-53. PubMed ID: 12400156
[TBL] [Abstract][Full Text] [Related]
3. Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions.
de Vries HE; Buchner B; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):638-45. PubMed ID: 10073968
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein.
Itabe H; Suzuki K; Tsukamoto Y; Komatsu R; Ueda M; Mori M; Higashi Y; Takano T
Biochim Biophys Acta; 2000 Sep; 1487(2-3):233-45. PubMed ID: 11018475
[TBL] [Abstract][Full Text] [Related]
5. Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36.
Guy RA; Maguire GF; Crandall I; Connelly PW; Kain KC
Atherosclerosis; 2001 Mar; 155(1):19-28. PubMed ID: 11223422
[TBL] [Abstract][Full Text] [Related]
6. Binding and uptake of differently oxidized low density lipoprotein in mouse peritoneal macrophages and THP-1 macrophages: involvement of negative charges as well as oxidation-specific epitopes.
Wang X; Greilberger J; Ledinski G; Kager G; Jürgens G
J Cell Biochem; 2001; 81(3):557-69. PubMed ID: 11255238
[TBL] [Abstract][Full Text] [Related]
7. Scavenger receptors, oxidized LDL, and atherosclerosis.
Boullier A; Bird DA; Chang MK; Dennis EA; Friedman P; Gillotre-Taylor K; Hörkkö S; Palinski W; Quehenberger O; Shaw P; Steinberg D; Terpstra V; Witztum JL
Ann N Y Acad Sci; 2001 Dec; 947():214-22; discussion 222-3. PubMed ID: 11795269
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low density lipoprotein: the occurrence and metabolism in circulation and in foam cells.
Itabe H; Takano T
J Atheroscler Thromb; 2000; 7(3):123-31. PubMed ID: 11480452
[TBL] [Abstract][Full Text] [Related]
9. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions.
Minami M; Kume N; Shimaoka T; Kataoka H; Hayashida K; Akiyama Y; Nagata I; Ando K; Nobuyoshi M; Hanyuu M; Komeda M; Yonehara S; Kita T
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1796-800. PubMed ID: 11701468
[TBL] [Abstract][Full Text] [Related]
10. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.
Podrez EA; Poliakov E; Shen Z; Zhang R; Deng Y; Sun M; Finton PJ; Shan L; Febbraio M; Hajjar DP; Silverstein RL; Hoff HF; Salomon RG; Hazen SL
J Biol Chem; 2002 Oct; 277(41):38517-23. PubMed ID: 12145296
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.
Chang MK; Binder CJ; Torzewski M; Witztum JL
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13043-8. PubMed ID: 12244213
[TBL] [Abstract][Full Text] [Related]
12. Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor.
Podrez EA; Hoppe G; O'Neil J; Hoff HF
Free Radic Biol Med; 2003 Feb; 34(3):356-64. PubMed ID: 12543251
[TBL] [Abstract][Full Text] [Related]
13. Oxidized LDL in carotid plaques and plasma associates with plaque instability.
Nishi K; Itabe H; Uno M; Kitazato KT; Horiguchi H; Shinno K; Nagahiro S
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1649-54. PubMed ID: 12377744
[TBL] [Abstract][Full Text] [Related]
14. Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation.
Holvoet P; Perez G; Bernar H; Brouwers E; Vanloo B; Rosseneu M; Collen D
J Clin Invest; 1994 Jan; 93(1):89-98. PubMed ID: 8282826
[TBL] [Abstract][Full Text] [Related]
15. Evidence that human Fc gamma receptor IIA (CD32) subtypes are not receptors for oxidized LDL.
Morganelli PM; Groveman DS; Pfeiffer JR
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3248-54. PubMed ID: 9409319
[TBL] [Abstract][Full Text] [Related]
16. [Oxidized low density lipoprotein receptors, including SR-PSOX, and atherogenesis].
Kume N
Seikagaku; 2001 Mar; 73(3):193-6. PubMed ID: 11321840
[No Abstract] [Full Text] [Related]
17. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein.
Itabe H; Yamamoto H; Suzuki M; Kawai Y; Nakagawa Y; Suzuki A; Imanaka T; Takano T
J Biol Chem; 1996 Dec; 271(52):33208-17. PubMed ID: 8969177
[TBL] [Abstract][Full Text] [Related]
18. The oxidant stress hypothesis of atherogenesis.
Iuliano L
Lipids; 2001; 36 Suppl():S41-4. PubMed ID: 11837991
[TBL] [Abstract][Full Text] [Related]
19. Non-conventional modification of low density lipoproteins: chemical models for macrophage recognition of oxidized LDL.
Hoppe G; O'Neil J; Sayre LM; Hoff HF
Biochim Biophys Acta; 1997 Dec; 1362(2-3):103-8. PubMed ID: 9540840
[TBL] [Abstract][Full Text] [Related]
20. Binding characteristics of scavenger receptors on liver endothelial and Kupffer cells for modified low-density lipoproteins.
De Rijke YB; Biessen EA; Vogelezang CJ; van Berkel TJ
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):69-73. PubMed ID: 7998959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
